pyridoxal phosphate has been researched along with Myelodysplastic Syndromes in 1 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of myelodysplastic syndromes is reviewed, with emphasis on recently published clinical trials." | 2.37 | Management of myelodysplastic syndromes. ( Buzaid, AC; Garewal, HS; Greenberg, BR, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buzaid, AC | 1 |
| Garewal, HS | 1 |
| Greenberg, BR | 1 |
1 review available for pyridoxal phosphate and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Management of myelodysplastic syndromes.
Topics: Androgens; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; | 1986 |